Innate Pharma S.A. (NASDAQ:IPHA) Long Term Investor Alert: Investigation over Potential Wrongdoing
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Innate Pharma S.A. was announced.
View full press release